vt3989
vivace therapeutics
['mesothelioma', 'concept data', 'vt3989']
researchers report clinical proof-of-concept data for vivace therapeutics' vt3989, a first for a cancer drug targeting the hippo pathway, in oral presentation at aacr 2023 liver tox, pot. cardic tox, low orr even if pot. interesting in mesothelioma 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)